Target intelligence / Profile preview

Siderophore hydroxamate moiety

Molecular classification
Other (Chemical moiety, not a discrete protein or receptor), Iron-chelating ligand
01

Overview

A siderophore hydroxamate moiety is a chemical functional group (C(=O)N(OH)R) found in many microbial siderophores—small molecules secreted to chelate ferric iron (Fe(III)) from the environment.[2][3][5] The hydroxamate group acts as a bidentate ligand, tightly binding Fe(III) with high selectivity. Siderophore hydroxamate moieties are present in various natural products (notably in fungi and bacteria) like ferrichrome, coprogen, and desferrioxamine[3][2]. They enable microbial iron acquisition, crucial for survival under iron-limiting conditions such as during host infection. In medicine, synthetic and natural hydroxamate siderophores (like desferrioxamine) are used as iron chelators, and hydroxamate-containing siderophores are being studied as potential vectors for antimicrobial payloads (Trojan horse antibiotics). The “siderophore hydroxamate moiety” is not itself a therapeutic target in the conventional sense (e.g., it is not a protein, enzyme, or receptor), but a structural component; drug discovery efforts often focus on exploiting microbial utilization of such moieties for selective drug delivery or as chelation agents.[5][2][3]

Other names
Hydroxamate siderophore moietyHydroxamate functional group (in siderophores)Hydroxamate chelator
02

Mechanism of action

Chelation of Fe(III) ions; Facilitation of iron transport into microbial cells; Drug delivery (Trojan horse mechanism for antibacterial agents)

03

Biological functions

Iron acquisition (in microbes)Metal chelation
04

Disease associations

Infection (relevant to pathogenic bacteria and antifungal/antibacterial drug design)
05

Safety considerations

Potential off-target iron chelation may influence host iron metabolismPossible interference with human iron homeostasis in therapeutic applications
06

Interacting drugs

Desferrioxamine (Deferoxamine; a clinically used iron chelator derived from a hydroxamate siderophore)

1 more in the full profile.

Beyond the preview

Go deeper on Siderophore hydroxamate moiety.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siderophore hydroxamate moiety.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call